Devlin Donald P. reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp reported that its SVP and Chief Financial Officer, Donald P. Devlin, received a grant of 281.2626 Dividend Equivalent Units (DEUs) on common stock. These DEUs accrued on previously granted restricted stock units and will vest and settle on the same terms as the original RSUs.
Each DEU represents the right to receive, subject to vesting, one share of Sylvamo common stock. Following this grant, Devlin directly holds a total of 822.5581 DEUs, reflecting routine compensation-related equity accrual rather than an open-market transaction.
Davoli Rodrigo reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp senior vice president and North America general manager Rodrigo Davoli received a routine equity-based compensation adjustment. On the reported date, he was granted 223.1022 dividend equivalent units (DEUs) tied to previously awarded restricted stock units at a reference price of $43.57 per unit.
According to the filing, each DEU represents the right, subject to vesting, to receive one share of Sylvamo common stock and will vest on the same schedule and terms as the original RSUs. Following this grant, Davoli holds a total of 1,362.1411 DEUs directly, reinforcing his long-term, stock-linked compensation without involving any open-market share purchases or sales.
Sylvamo Corp reported that SVP, Chief Admin & Legal Matthew Barron acquired 156.6893 dividend equivalent units (DEUs) on restricted stock units (RSUs) as of April 28, 2026. These DEUs accrued as dividend equivalents on previously granted RSUs, at a reference price of $43.57 per unit.
After this grant, Barron directly holds 1,368.9727 DEUs. Each DEU represents the right to receive, subject to vesting, one share of Sylvamo common stock and will vest and be settled on the same terms and conditions as the original RSUs to which they relate.
Sylvamo Corporation is asking shareowners to vote on three items at its 2026 annual meeting: electing seven directors, ratifying Deloitte & Touche LLP as independent auditor, and approving on an advisory basis the compensation of named executive officers, with the board recommending FOR all items.
The proxy details a refreshed leadership structure, with John V. Sims serving as Chief Executive Officer and President and David Petratis as independent Chairman. It highlights strong governance practices, including independent board committees, director overboarding limits, mandatory retirement at 75, and restrictions on short sales, pledging and hedging.
Executive pay is built around a pay-for-performance model using base salary, an annual cash incentive tied to Free Cash Flow and Adjusted EBITDA Margin, and a long-term equity plan based on Return on Invested Capital and relative Total Shareholder Return. For 2025, Sylvamo generated Free Cash Flow of $44 million, Adjusted EBITDA Margin of 13.7%, three‑year average ROIC of 18.7%, and three‑year total shareholder return of 10.3%, while paying a quarterly dividend of $0.45 per share.
Sylvamo Corp Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned of Sylvamo Corp common stock and 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, causing disaggregated reporting by Vanguard subsidiaries.
Sylvamo Corp senior vice president of operational excellence Patrick Wilczynski reported an open-market sale of 6,000 shares of common stock at an average price of $42.28 per share on 2026-03-17.
After this transaction, he holds 38,313.3962 shares directly and 608.57 shares indirectly through his spouse.
Sylvamo Corp executive Kevin W. Ferguson, VP, Controller and Chief Accounting Officer, reported an open-market sale of 2,500 shares of common stock on March 9, 2026.
The shares were sold at an average price of $42.06 per share, noted as an average sale price. After this transaction, he directly owned 6,256.9526 shares of Sylvamo common stock.
Sylvamo Corporation has filed a shelf registration to permit the resale of 6,312,454 shares of common stock by the identified selling stockholders.
The prospectus states the company is not selling any shares hereunder and will receive no proceeds from resales. The registration is being maintained under a Cooperation Agreement and will remain effective through August 13, 2026. Shares outstanding were 39,508,464 as of March 1, 2026, which is presented as context in the prospectus.